Navigation Links
AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
Date:10/28/2008

QUEBEC CITY, Oct. 28 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its Senior Vice President and Chief Medical Officer, Paul Blake, MD, will present a company overview at the upcoming Oppenheimer 19th Annual Healthcare Conference on Monday, November 3, 2008 at 8:00 am (Eastern Time), in the Basildon Room of the Waldorf-Astoria Hotel in New York City.

A live webcast of the presentation will be available on AEterna Zentaris' website at http://www.aezsinc.com in the Investors section. A replay will also be available for a period of 30 days on the Company's website.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aezsinc.com.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
2. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
3. AEterna Zentaris to Present at BioContact Quebec on October 2, 2008
4. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
5. AEterna Zentaris Reports Second Quarter 2008 Financial and Operating Results
6. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
7. AEterna Zentaris to Announce Second Quarter 2008 Financial and Operating Results on August 12, 2008
8. AEterna Zentaris Sells Quebec City Building for $7.1 million
9. AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting
10. AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
11. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... TORONTO, May 5, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... financial results for the three months ended March 31, ... all amounts are in Canadian dollars. ... year end from May 31 to December 31. As ... being reported is for the three months ended March ...
(Date:5/5/2015)... 5, 2015  23andMe, Inc., the leading personal genetics ... Research Study in collaboration with Pfizer Inc. The ... erythematosus, more commonly known as lupus, into the study ... effort is also in collaboration with the Lupus Research ... May. Approximately 1.5 million people in the ...
(Date:5/5/2015)... Mich. (PRWEB) May 05, 2015 ... publishing services to develop custom course materials for smaller ... annual enrollments as low as 200 students. , ... a broader range of higher education instructors,” said Jeff ... the country, we can do our part to make ...
(Date:5/5/2015)... -- Psyche Systems Corporation and Luminate Health have recently ... that helps labs comply with new federal HHS legislation ... patients engage with these results, and improves provider workflow. ... HIPAA-compliant digital platform that gives labs an easy way ... results, and uniquely connects labs, physicians, and patients with ...
Breaking Biology Technology:Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 823andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 3Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2Psyche Systems Corporation Forms Strategic Alliance with Luminate Health to Provide First-of-its-kind Patient Access Solution 2Psyche Systems Corporation Forms Strategic Alliance with Luminate Health to Provide First-of-its-kind Patient Access Solution 3
... Discovery Research, Wyeth Research, CN-8000, Princeton, NJ 08543. , , , ... , HIGHER THROUGHPUT , ... RESCUES SUB-OPTIMAL ASSAYS , , ... ABSTRACT , FLIPR Calcium 3 Assay Kit (Calcium 3), ...
... ASSAYS, , , , , ... DATA , , HIGHER THROUGHPUT ... , Every major pharmaceutical company uses the,Molecular Devices FLIPR ... Calcium Assay Kit from Molecular,Devices provides the easiest way to ...
... , Evelyn McGown, Ph.D. , Michael Su, M.S. and Jin Liao, ... Molecular Devices Corporation, 8/00 , ... North American firefly (Photinus pyralis) is very popular foruse in Reporter ... concomitant release of light (Figure 1) 1 . When luciferase is ...
Cached Biology Technology:FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses 2FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses 3FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses 4FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses 5FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses 6FLIPR Calcium Assay Kit Datasheet 2FLIPR Calcium Assay Kit Datasheet 3Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38) 2Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38) 3Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38) 4
(Date:4/6/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market, announced today ... MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM FOR ... introduces a new revolutionary method and system to ... of miniature antenna modules for multiple purposes including ...
(Date:4/1/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces the second shipment ... underway to early access pre-order customers. ... retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop ... accepted at all outlets and very easy to use. ...
(Date:3/26/2015)... The Granite Club, ... club, today announced it has implemented a state-of-the-art access ... for members and staff, while restricting access to authorized ... selected FST,s IMID Access system because it has the ... and staff, in addition to unparalleled security," said ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... of crab is spreading at an alarming rate throughout ... , The Chinese mitten crab, brought to Britain during ... devastating environmental problems if populations are not monitored and ... the University of Newcastle upon Tyne carried out the ...
... of New Jersey, believe they have located a place ... their parents' songs. The discovery has implications for humans, ... that learn to vocalize by imitating their caregivers. , ... the National Academy of Sciences, David Vicario and Mimi ...
... feat of plant biotechnology and vaccine design, researchers in ... turned tobacco plants into vaccine production factories to combat ... protective immune response in guinea pigs. The results are ... of a new vaccine for human use. , Plague, ...
Cached Biology News:Exotic crab poised for widespread UK invasion 2Exotic crab poised for widespread UK invasion 3Zebra finches remember songs dad sang 2Zebra finches remember songs dad sang 3Plant-derived vaccines safeguard against deadly plague 2Plant-derived vaccines safeguard against deadly plague 3
Request Info...
Mouse monoclonal [3G131] to Desmoglein 1 ( Abpromise for all tested applications). entrezGeneID: 1828 SwissProtID: Q02413...
TCP-1 alpha (H-110)...
Synphilin 1 Immunogen: Synthetic peptide corresponding to residues S(829) L E L N G E K D K D K G R T L Q R T(847) of human Synphilin 1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: